Introduction: Why Pharmacometabolomics is important.
Pharmacometabolomics is improving medication therapy by providing a better knowledge of how a person's unique metabolic profile influences how he or she will respond to pharmaceuticals. While classical pharmacology frequently relies on averages, pharmacometabolomics takes a completely different approach, examining the complex interplay of genetics, gut microbiome, age, and other variables that influence drug absorption, distribution, and biliary or conjugate hepatic metabolism. Individualizing medication treatments has the potential to improve efficacy while lowering negative effects, resulting in truly tailored medicine.
Pioneering Innovation in Pharmacometabolomics
Perhaps the most groundbreaking discovery in pharmacometabolomics is the existence of specific, identifiable metabolites whose activity alters the drug's efficacy. These insights are already being applied to specific changes—scientists may now modify individual metabolites to boost therapeutic efficacy. This discipline combines advanced research methodologies with the practical use of molecular and metabolic profiling. Recent study, for example, shows how analyzing a patient's metabolic fingerprint before to treatment might help identify which medications will be most beneficial, reducing the need for trial-and-error medicine.
Why This Call for Papers is Beneficial to Scholars
This Call for Papers to Scientific Reports is a special call to scientists performing innovative research on pharmacometabolomics and drug-metabolite interactions. By contributing, scientists can showcase unique approaches and findings that improve personalized medicine. This Collection, published by well-known specialists from Indonesia and Korea, promotes cross-disciplinary cooperation and exposure to international research communities. Contributing your work not only accelerates advancement in the field, but it also positions you at the forefront of personalized drug therapy and biomarker identification. Don't miss the June 15, 2026, submission deadline, which represents a unique opportunity for you to make a difference in biomedical science and clinical pharmacology.
If you are interested in this initiative, you may look for the official link for the call of paper in here
Guest Editors:
- Adam Hermawan, PhD, Universitas Gadjah Mada
- Jeongmi Lee, PhD, Sungkyunkwan University, Republic of Korea
- Dr. Arli Aditya Parikesit, i3L University